The health authorities granted authorization to market the drug Molnupiravir, marketed by the American laboratory Merck, against the emerging coronavirus (Covid-19). “The anti-covid-19 drug from the American laboratory Merck will be available in Morocco in the coming days,” said Dr. Said Moutawakil, member of the Covid-19 technical and scientific committee.
In a statement, the expert clarified that “the Directorate of Drugs and Pharmacy (DMP) has given marketing authorization for Molnupiraver, after several months of negotiations with the American laboratory”. “Once available, this treatment will be included in the treatment protocol,” he promised.
Dr. Said Moutawakil added that “Morocco has started negotiations to buy Pfizer’s pills, but also drugs manufactured by Chinese and Hindu laboratories which are under investigation.” “The vaccine is an excellent solution to limit the spread of the virus, but it is not sufficient, on its own, to cope with the virus, especially in the face of this vaccine escape phenomenon”, he noted before ensuring that “drugs, vaccines and barrier measures will be our weapons to deal with the spread of the pandemic”.
Molnupiravir is an experimental broad-spectrum antiviral, initially intended to treat influenza and hepatitis C, but which has shown its effectiveness against various coronaviruses including SARS-CoV-2 responsible for Covid-19.
The pill against Covid-19 from the Merck laboratory was urgently authorized, Thursday, December 23, by the United States Food and Drug Administration (FDA), the day after the authorization of a similar pill developed by Pfizer.